Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cryosite Limited (AU:CTE)
ASX:CTE
Holding AU:CTE?
Track your performance easily
CTE Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.55 - AU$1.32
Previous CloseAU$0.86
Volume1.11K
Average Volume (3M)36.84K
Market Cap
AU$41.73M
Enterprise ValueAU$37.24M
Total Cash (Recent Filing)AU$5.34M
Total Debt (Recent Filing)AU$849.76K
Price to Earnings (P/E)22.7
Beta-0.46
Next Earnings
Feb 20, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 06, 2024Dividend Yield7.95%
Share Statistics
EPS (TTM)0.04
Shares OutstandingN/A
10 Day Avg. Volume60,814
30 Day Avg. Volume36,839
Standard Deviation0.26
R-Squared0.00142
Alpha0.08
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)3.14
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Cryosite Limited News
PremiumCompany Announcements
Cryosite Limited Announces 2024 Annual General Meeting
PremiumCompany Announcements
Cryosite Limited Shares Company Update
PremiumCompany Announcements
Cryosite Limited Reports Growth and Leadership ChangesPremiumCompany Announcements
Cryosite Enhances Governance for Shareholder Value
PremiumCompany Announcements
Cryosite Limited Declares Upcoming DividendPremiumCompany Announcements
Cryosite Limited Announces Strong Annual Growth
PremiumCompany Announcements
Cryosite Director’s Final Holdings RevealedOptions Prices
Currently, No data available
---
Ownership Overview
CTE FAQ
What was Cryosite Limited’s price range in the past 12 months?
Cryosite Limited lowest share price was AU$0.55 and its highest was AU$1.32 in the past 12 months.
What is Cryosite Limited’s market cap?
Currently, no data Available
When is Cryosite Limited’s upcoming earnings report date?
Cryosite Limited’s upcoming earnings report date is Feb 20, 2025 which is in 90 days.
How were Cryosite Limited’s earnings last quarter?
Cryosite Limited released its earnings results on Aug 20, 2024. The company reported AU$0.02 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.02.
Is Cryosite Limited overvalued?
According to Wall Street analysts Cryosite Limited’s price is currently Overvalued.
Does Cryosite Limited pay dividends?
Cryosite Limited pays a Annually dividend of AU$0.02 which represents an annual dividend yield of 7.95%. See more information on Cryosite Limited dividends here
What is Cryosite Limited’s EPS estimate?
Cryosite Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cryosite Limited have?
Cryosite Limited has 48,809,563 shares outstanding.
What happened to Cryosite Limited’s price movement after its last earnings report?
Cryosite Limited reported an EPS of AU$0.02 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cryosite Limited?
Currently, no hedge funds are holding shares in AU:CTE
---
Cryosite Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
48.18%
12-Months-Change
Fundamentals
Return on Equity
86.98%
Trailing 12-Months
Asset Growth
-12.96%
Trailing 12-Months
Company Description
Cryosite Limited
Cryosite Ltd is engaged in the provision of supply chain logistics, management of pharmaceutical products used in clinical trials. The company's operating segment includes Cord Blood and Tissue Storage and Clinical Trials and Biological Services Logistics. It generates maximum revenue from the Clinical Trials and Biological Services Logistics segment. Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services.
---
Technical Analysis
---